Baltimore biotechnology firm WindMIL Therapeutics has raised a $32.5 million to support clinical trials and further development for new cancer therapies. The Series B round was led by QiMing USA Venture Partners, the new U.S. entity of China firm QiMing. WindMIL, a cell therapy company, is previously backed by about $11 million in funding. WindMIL was founded out of Johns Hopkins University by researchers Kimberly Noonan and Dr. Ivan Borrello. The clinical stage company is working to develop…
from https://www.bizjournals.com/baltimore/news/2018/06/18/baltimore-biotech-windmil-therapeutics-raises-32-5.html?ana=RSS&s=article_search
via http://baltimorecheckbook.tumblr.com/post/175007331302
No comments:
Post a Comment